Differentiation of neuromyelitis optica from multiple sclerosis on spinal magnetic resonance imaging
- PMID: 24453753
- PMCID: PMC3882989
- DOI: 10.7224/1537-2073-14.4.209
Differentiation of neuromyelitis optica from multiple sclerosis on spinal magnetic resonance imaging
Abstract
In order to examine the accuracy of magnetic resonance imaging (MRI)-based diagnosis of neuromyelitis optica (NMO) versus multiple sclerosis (MS), we performed a retrospective, rater-blinded review of 29 cases of NMO and 30 cases of MS using the criteria of long (more than three vertebral levels), continuous lesions with a central cord location for NMO and more peripheral and patchy lesions for MS. Using these criteria, two raters were able to distinguish the two conditions with a good degree of confidence, particularly when the imaging was performed at the time of an acute cord attack. The sensitivity and specificity for diagnosis of NMO were 86.2% and 93.3%, respectively, for Rater A and 96.4% and 78.6%, respectively, for Rater B, with a kappa value of 0.72. Thus there are significant differences in lesion characteristics that allow the distinction on spinal cord imaging between MS and NMO with a moderately high degree of confidence. The location of the lesion as evident on MRI of the spine can be regarded as a distinguishing diagnostic feature between MS and NMO.
Figures



Similar articles
-
"Bright spotty lesions" on spinal magnetic resonance imaging differentiate neuromyelitis optica from multiple sclerosis.Mult Scler. 2014 Mar;20(3):331-7. doi: 10.1177/1352458513495581. Epub 2013 Jul 4. Mult Scler. 2014. PMID: 23828869
-
Revised diagnostic criteria for neuromyelitis optica.Neurology. 2006 May 23;66(10):1485-9. doi: 10.1212/01.wnl.0000216139.44259.74. Neurology. 2006. PMID: 16717206
-
Brain abnormalities in neuromyelitis optica.Arch Neurol. 2006 Mar;63(3):390-6. doi: 10.1001/archneur.63.3.390. Arch Neurol. 2006. PMID: 16533966
-
Diagnosis and treatment of neuromyelitis optica.Neurologist. 2007 Jan;13(1):2-11. doi: 10.1097/01.nrl.0000250927.21903.f8. Neurologist. 2007. PMID: 17215722 Review.
-
Devic's neuromyelitis optica: a critical review.Arq Neuropsiquiatr. 2008 Mar;66(1):120-38. doi: 10.1590/s0004-282x2008000100034. Arq Neuropsiquiatr. 2008. PMID: 18392436 Review.
Cited by
-
Comprehensive review of neuromyelitis optica and clinical characteristics of neuromyelitis optica patients in Puerto Rico.Surg Neurol Int. 2018 Dec 3;9:242. doi: 10.4103/sni.sni_224_18. eCollection 2018. Surg Neurol Int. 2018. PMID: 30603227 Free PMC article. Review.
-
Linking Downbeat Nystagmus and Aquaporin-4-Positive Neuromyelitis Optica: A Closer Look at Their Hidden Relationship.Cureus. 2024 Oct 20;16(10):e71927. doi: 10.7759/cureus.71927. eCollection 2024 Oct. Cureus. 2024. PMID: 39564022 Free PMC article.
-
Reduction in circulating vitamin D binding protein in patients with multiple sclerosis.BMC Neurol. 2021 Apr 20;21(1):168. doi: 10.1186/s12883-021-02200-0. BMC Neurol. 2021. PMID: 33879066 Free PMC article.
-
CD40-Mediated NF-κB Activation in B Cells Is Increased in Multiple Sclerosis and Modulated by Therapeutics.J Immunol. 2016 Dec 1;197(11):4257-4265. doi: 10.4049/jimmunol.1600782. Epub 2016 Oct 26. J Immunol. 2016. PMID: 27798157 Free PMC article.
-
Influence of STAT4 Genetic Variants and Serum Levels on Multiple Sclerosis Occurrence in the Lithuanian Population.J Clin Med. 2024 Apr 19;13(8):2385. doi: 10.3390/jcm13082385. J Clin Med. 2024. PMID: 38673659 Free PMC article.
References
-
- Rodriguez M. Have we finally identified an autoimmune demyelinating disease? Neurology. 2009;66:572–573. - PubMed
-
- Wingerchuk DM,, Hogancamp WF,, O'Brien PC,, Weinshenker BG. The clinical course of neuromyelitis optica (Devic's syndrome) Neurology. 1999;53:1107–1114. - PubMed
-
- Cree BAC,, Goodin DS,, Hauser SL. Neuromyelitis optica [review] Semin Neurol. 2002;22:105–122. - PubMed
-
- Wingerchuk DM. Neuromyelitis optica: current concepts. Front Biosci. 2004;9:834–840. - PubMed
LinkOut - more resources
Full Text Sources